Verndari begins preclinical testing of COVID-19 vaccine candidate
Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. The preclinical testing will be carried out in laboratories at the University of California in Davis (UC Davis). Verndari, which was established in 2015, is said to have developed the […]